Connect With Us:
REPORT ID 3652

Global Gastrointestinal Drugs Sales Market Report 2017

Publish Date
14-Dec-17
Pages
100
Format
Electronic (PDF)

Full report description 
In this report, the global Gastrointestinal Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Gastrointestinal Drugs for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Gastrointestinal Drugs market competition by top manufacturers/players, with Gastrointestinal Drugs sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AstraZeneca
    Johnson & Johnson
    Salix Pharma
    Takeda Pharma
    Eisai
    Shire
    Allergan
    ...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Capsules
    Inhalants
    Parenterals
    Tablets
    Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Antacid & Anti-Ulcerant
    GIT Anti-inflammatory
    Antiemetic
    Anti-diarrhoea
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.
Table of contents 
Table of Contents

Global Gastrointestinal Drugs Sales Market Report 2017
1 Gastrointestinal Drugs Market Overview
    1.1 Product Overview and Scope of Gastrointestinal Drugs
    1.2 Classification of Gastrointestinal Drugs by Product Category
        1.2.1 Global Gastrointestinal Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Gastrointestinal Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Capsules
        1.2.4 Inhalants
        1.2.5 Parenterals
        1.2.6 Tablets
        1.2.7 Other
    1.3 Global Gastrointestinal Drugs Market by Application/End Users
        1.3.1 Global Gastrointestinal Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Antacid & Anti-Ulcerant
        1.3.3 GIT Anti-inflammatory
        1.3.4 Antiemetic
        1.3.5 Anti-diarrhoea
        1.3.6 Other
    1.4 Global Gastrointestinal Drugs Market by Region
        1.4.1 Global Gastrointestinal Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Gastrointestinal Drugs Status and Prospect (2012-2022)
        1.4.3 China Gastrointestinal Drugs Status and Prospect (2012-2022)
        1.4.4 Europe Gastrointestinal Drugs Status and Prospect (2012-2022)
        1.4.5 Japan Gastrointestinal Drugs Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Gastrointestinal Drugs Status and Prospect (2012-2022)
        1.4.7 India Gastrointestinal Drugs Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Gastrointestinal Drugs (2012-2022)
        1.5.1 Global Gastrointestinal Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Global Gastrointestinal Drugs Revenue and Growth Rate (2012-2022)

2 Global Gastrointestinal Drugs Competition by Players/Suppliers, Type and Application
     2.1 Global Gastrointestinal Drugs Market Competition by Players/Suppliers
        2.1.1 Global Gastrointestinal Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Gastrointestinal Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Gastrointestinal Drugs (Volume and Value) by Type
        2.2.1 Global Gastrointestinal Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Global Gastrointestinal Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Global Gastrointestinal Drugs (Volume and Value) by Region
        2.3.1 Global Gastrointestinal Drugs Sales and Market Share by Region (2012-2017)
        2.3.2 Global Gastrointestinal Drugs Revenue and Market Share by Region (2012-2017)
    2.4 Global Gastrointestinal Drugs (Volume) by Application

3 United States Gastrointestinal Drugs (Volume, Value and Sales Price)
    3.1 United States Gastrointestinal Drugs Sales and Value (2012-2017)
        3.1.1 United States Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        3.1.2 United States Gastrointestinal Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 United States Gastrointestinal Drugs Sales Price Trend (2012-2017)
    3.2 United States Gastrointestinal Drugs Sales Volume and Market Share by Players
    3.3 United States Gastrointestinal Drugs Sales Volume and Market Share by Type
    3.4 United States Gastrointestinal Drugs Sales Volume and Market Share by Application

4 China Gastrointestinal Drugs (Volume, Value and Sales Price)
    4.1 China Gastrointestinal Drugs Sales and Value (2012-2017)
        4.1.1 China Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        4.1.2 China Gastrointestinal Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 China Gastrointestinal Drugs Sales Price Trend (2012-2017)
    4.2 China Gastrointestinal Drugs Sales Volume and Market Share by Players
    4.3 China Gastrointestinal Drugs Sales Volume and Market Share by Type
    4.4 China Gastrointestinal Drugs Sales Volume and Market Share by Application

5 Europe Gastrointestinal Drugs (Volume, Value and Sales Price)
    5.1 Europe Gastrointestinal Drugs Sales and Value (2012-2017)
        5.1.1 Europe Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        5.1.2 Europe Gastrointestinal Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Gastrointestinal Drugs Sales Price Trend (2012-2017)
    5.2 Europe Gastrointestinal Drugs Sales Volume and Market Share by Players
    5.3 Europe Gastrointestinal Drugs Sales Volume and Market Share by Type
    5.4 Europe Gastrointestinal Drugs Sales Volume and Market Share by Application

6 Japan Gastrointestinal Drugs (Volume, Value and Sales Price)
    6.1 Japan Gastrointestinal Drugs Sales and Value (2012-2017)
        6.1.1 Japan Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        6.1.2 Japan Gastrointestinal Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Gastrointestinal Drugs Sales Price Trend (2012-2017)
    6.2 Japan Gastrointestinal Drugs Sales Volume and Market Share by Players
    6.3 Japan Gastrointestinal Drugs Sales Volume and Market Share by Type
    6.4 Japan Gastrointestinal Drugs Sales Volume and Market Share by Application

7 Southeast Asia Gastrointestinal Drugs (Volume, Value and Sales Price)
    7.1 Southeast Asia Gastrointestinal Drugs Sales and Value (2012-2017)
        7.1.1 Southeast Asia Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Gastrointestinal Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Gastrointestinal Drugs Sales Price Trend (2012-2017)
    7.2 Southeast Asia Gastrointestinal Drugs Sales Volume and Market Share by Players
    7.3 Southeast Asia Gastrointestinal Drugs Sales Volume and Market Share by Type
    7.4 Southeast Asia Gastrointestinal Drugs Sales Volume and Market Share by Application

8 India Gastrointestinal Drugs (Volume, Value and Sales Price)
    8.1 India Gastrointestinal Drugs Sales and Value (2012-2017)
        8.1.1 India Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        8.1.2 India Gastrointestinal Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 India Gastrointestinal Drugs Sales Price Trend (2012-2017)
    8.2 India Gastrointestinal Drugs Sales Volume and Market Share by Players
    8.3 India Gastrointestinal Drugs Sales Volume and Market Share by Type
    8.4 India Gastrointestinal Drugs Sales Volume and Market Share by Application

9 Global Gastrointestinal Drugs Players/Suppliers Profiles and Sales Data
    9.1 AstraZeneca
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Gastrointestinal Drugs Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Johnson & Johnson
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Gastrointestinal Drugs Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Johnson & Johnson Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Salix Pharma
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Gastrointestinal Drugs Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Salix Pharma Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Takeda Pharma
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Gastrointestinal Drugs Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Takeda Pharma Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Eisai
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Gastrointestinal Drugs Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Eisai Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Shire
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Gastrointestinal Drugs Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Shire Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Allergan
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Gastrointestinal Drugs Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Allergan Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    ...

10 Gastrointestinal Drugs Maufacturing Cost Analysis
    10.1 Gastrointestinal Drugs Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Gastrointestinal Drugs
    10.3 Manufacturing Process Analysis of Gastrointestinal Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Gastrointestinal Drugs Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Gastrointestinal Drugs Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Gastrointestinal Drugs Market Forecast (2017-2022)
    14.1 Global Gastrointestinal Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Gastrointestinal Drugs Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Gastrointestinal Drugs Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Gastrointestinal Drugs Price and Trend Forecast (2017-2022)
    14.2 Global Gastrointestinal Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Gastrointestinal Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Gastrointestinal Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Gastrointestinal Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Gastrointestinal Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Gastrointestinal Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Gastrointestinal Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Gastrointestinal Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Gastrointestinal Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Gastrointestinal Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Gastrointestinal Drugs Sales Forecast by Type (2017-2022)
       14.3.2 Global Gastrointestinal Drugs Revenue Forecast by Type (2017-2022)
       14.3.3 Global Gastrointestinal Drugs Price Forecast by Type (2017-2022)
    14.4 Global Gastrointestinal Drugs Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer